A non-invasive tape absorption method for recovery of inflammatory mediators to differentiate normal from compromised scalp conditions

Skin Research and Technology

Volumn 8, Issue 3, 2002, Pages 187-193

  Perkins, M A ^a   Cardin, C W ^a   Osterhues, M A ^a   Robinson, M K ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Cytokiens and molecular markers; Dundruff; Non invasive method; Scalp; Seborrhea; Sebutape

Indexed keywords

AUTACOID; BUFFER; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; NITRIC OXIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DANDRUFF; DIAGNOSTIC VALUE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MEDICAL SPECIALIST; NON INVASIVE MEASUREMENT; SCALP; SCORING SYSTEM; SEBORRHEIC DERMATITIS; SKIN DISEASE; TREATMENT OUTCOME;

ABSORPTION; CYTOKINES; DERMATITIS, SEBORRHEIC; DERMATOLOGY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOASSAY; INFLAMMATION MEDIATORS; NITRIC OXIDE; REFERENCE VALUES; SCALP; SCALP DERMATOSES;

EID: 0036380483     PISSN: 0909752X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0846.2002.20337.x     Document Type: Article

References (15)

1. Grabbe S, Luger TA. The skin as an immunological organ as well as a target for immune responses. In: Kater L, Baart de la Faille H, Eds. Multi-Systemic Autoimmune Diseases, New York: Elsevier Science BV 1995, 17-41.
2. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482-487.
3. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with irritation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30: 535-546.
4. Kligman AM. The invisible dermatoses. Arch Dermatol 1991; 127: 1375-1382.
5. Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM. Interleukin-1a is present in normal human epidermis. J Immunol 1986; 136: 3317-3323.
6. Feliciani C, Gupta AK, Sauder DN. Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med 1996; 8: 300-318.
7. Hirao T, Aoki H, Yoshida T, Sato Y, Kamoda H. Elevation of interleukin-1 receptor antagonist in the stratum corneum of sun-exposed and ultraviolet B-irradiated human skin. J Invest Dermatol 1996; 106: 1102-1107.
8. Terui T, Hirao T, Sato Y, Uesugi T, Honda M, Iguchi M, Matsmura N, Kudoh K, Aiba S, Tagami H. An increased ratio of interleukin-receptor antagonist to interleukin-1α in inflammatory skin diseases. Exp Dermatol 1998; 7: 327-334.
9. Perkins MA, Osterhues MA, Farage MA, Robinson MK. Development of noninvasive methods to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation. Skin Res Technol 2001; 7: 227-237.
10. Pierard-Franchimont C, Hermanns JF, Degreef H, Pierard GE. From axioms to new insights into dandruff. Dermatology 2000; 200: 93-98.
11. Shuster S, Blachford N. Seborrhoeic dermatitis and dandruff-A fungal disease. London. Royal Society Of Medical Publishers 1988, 1-30.
12. Hay RJ, Graham Brown RAC. Dandruff and seborrhoeic dermatitis. Causes Manage Clin Exp Dermatolog 1997; 22: 3-6.
13. Bruch-Gerharz D, Ruszika T, Kolb-Bachofen V. Nitric oxide and its implications in skin homeostasis and disease-A review. Arch Derm Res 1998; 290: 643-651.
14. Code of Federal Regulations specified under 21 CFR, 321.66.
15. Walsh SV, Hopkins AM, Nusrat A. Modulation of tight junction structure and function by cytokines. Advanced Drug Delivery Rev 2000; 41: 303-313.